Global Search | Novartis

Sort by

Relevance

Newest first

Oldest first

Hide Filters

Showing 2764 results

Clinical Trials / Oct 31, 2025

Secukinumab Open Label Roll-over Extension Protocol
Clinical Trials / Sep 16, 2025

Phase I/II Study of [225Ac]Ac-PSMA-R2 in PSMA-positive Prostate Cancer, With/Without Prior 177Lu-PSMA RLT
Clinical Trials / Oct 16, 2025

Safety and Efficacy Study of Fingolimod in Taiwanese Adults (≥ 20years) With Relapsing Remitting Multiple Sclerosis
Clinical Trials / Jun 29, 2025

24 Weeks Double-blind Randomized Placebo-controlled Trial to Evaluate Efficacy, PK, Safety of LOU064 in Adolescents (12 - <18) With CSU and Inadequate Response to H1-antihistamine Followed by Optional 3 Years Open-label Extension and an Optional 3 Years Safety Long-term Treatment-free Follow-up
Clinical Trials / Nov 26, 2025

Safety, Efficacy and Tolerability of Ianalumab Versus Placebo, Combination With SoC Therapy, in Participants With Active Lupus Nephritis
Media Library / Dec 04, 2025

Honor Protected - Doc Url
Media Library / Dec 04, 2025

Honor Protected - Doc file
Press release / Oct 29, 2025

Novartis ianalumab first drug to reduce disease activity and patient burden in Sjögren’s disease Phase III trials

NEPTUNUS-1 and NEPTUNUS-2 achieved primary objective of reduced disease activity and provided clinically meaningful benefit1 Data showed consistent improvements across secondary…
Media Library / Dec 04, 2025

testML
Media Library / Dec 04, 2025

test

‹ Previous page
1
…
15
16
17
18
19
20
21
…
277
› Next page